Examinando por Materia "Patente"

Mostrando 1 - 2 de 2
  • No hay miniatura disponible
    Ítem
    El blockchain y la propiedad intelectual en Colombia : perspectivas como medio de protección y como objeto de protección
    (Universidad EAFIT, 2022) Gómez Molina, Simón; Múnera Posada, Armando
    The purpose of this research is to study the Blockchain in Colombia as a means of protection and, secondly, as an object of intellectual property protection. In this sense, the difficulties present in the Colombian legal framework related to the use of Blockchain technology as a means of protection are discussed, with a view to seeking strategies to solve this problem. Regarding the methodology, the research is limited to a documentary-bibliographic research, in which the techniques for the collection and analysis of the data are the analysis of the normative hypothesis, the consultation to sources of legal knowledge and the review of the data obtained for the interpretation of the legal facts; thus, from the analysis and interpretation it was concluded that despite the advantages of the technology studied in intellectual protection, it is visualized that there are few institutions and professionals with sufficient knowledge to contribute ideas on this topic, so that a legal set for the use of the tool has not been consolidated.
  • No hay miniatura disponible
    Ítem
    Flexibilización de los requisitos de patentabilidad y derechos de exclusividad de datos de pruebas en el régimen jurídico de propiedad intelectual aplicable a los medicamentos en Colombia
    (Universidad EAFIT, 2022) Zurek Peñaloza, Eduardo Andrés; Toro Valencia, José Alberto; Barboza Vergara, Antonio Carlos
    This study aims to explain how the intellectual property protection regime for pharmaceuticals in Colombia has become more flexible as a result of the diplomatic influence, as well as through international agreements, exercised by more developed States. For this purpose, the application of patentability standards and the protection of exclusivity of trial data will be taken into account.